Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on April 30, 2019. The filing reports on the Company's financial performance for the first fiscal quarter ended March 31, 2019. Note: The request metadata references "Clearpoint Neuro, Inc.," but the filing text explicitly identifies the registrant as "MRI Interventions, Inc."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification that a press release containing these details (Exhibit 99.1) has been issued, but the metrics themselves are not embedded in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that the Company announced its Q1 2019 results via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for MRI Interventions, Inc., not Clearpoint Neuro, Inc.
- Locate and review Exhibit 99.1 (Press Release dated April 30, 2019) for actual financial figures, as they are absent from the 8-K text.
- Confirm the fiscal quarter end date of March 31, 2019, for accurate period comparison.
- Note that the financial data in the press release is not legally "filed" under Section 18 of the Exchange Act per the disclaimer in this report.